Influenza Diagnostics Market Unlock the Future: 2030 Market Report and Forecast


Global Influenza Diagnostics Market Size Was Valued at USD 1.11 Billion in 2022, and is Projected to Reach USD 1.47 Billion by 2030, Growing at a CAGR of 3.6% From 2023-2030.

Influenza_Diagnostics_Market

Global Influenza Diagnostics Market Size Was Valued at USD 1.11 Billion in 2022, and is Projected to Reach USD 1.47 Billion by 2030, Growing at a CAGR of 3.6% From 2023-2030.

Influenza, also referred to as the flu, is a virus-induced respiratory illness. Usually, coughing or sneezing is how the flu virus spreads from person to person. Furthermore, touching the nose or eyes after coming into contact with a surface contaminated with the flu virus might also result in contracting the illness. Seasonal flu refers to the periods of the year when the flu is most common.

The flu season in the US can start as early as October and last until May. Millions of Americans contract the flu virus each flu season. People who have the flu frequently have fever, aches in their muscles, and other uncomfortable symptoms, but they usually get well in a week. For certain individuals, influenza can result in a severe illness and in rare circumstances, even result in death. The development of the influenza diagnostic market is anticipated over the projected period as a result of influenza diagnostic tests' ability to help healthcare providers identify and treat patients with the virus early on.

Global Influenza Diagnostics Market Top Key Players:

Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-LA Roche AG (Switzerland), Abbott Laboratories Inc. (Us), Hologic Inc. (US), SEKISUI Diagnostics (US), Quidel Corporation (US), Germaine Laboratories Inc. (US), Dickinson and Company (US), Meridian Bioscience (US), GenMark Diagnostics Inc. (US), Luminex Corporation (US), SA Scientific Ltd. (US), bioMérieux SA (France), Tecan Trading AG (Switzerland), DiaSorin SA (Italy), altona Diagnostics GmbH (Germany), Coris BioConcept SPRL (Belgium), ELITech Group (France), Mast Group Ltd. (UK), Genome Diagnostics Pvt. Ltd. (India), Response Biomedical Corp. (Canada), Tauns LaboratoriesInc. (Japan), 3B BlackBio Biotech India Ltd. (India)

Customize Your Solution That Fit Within the Constraints of Your Annual Budget.!

https://introspectivemarketresearch.com/request/15919

Introspective Market Research provide comprehensive market research studies, delivering valuable insights and strategic guidance to businesses worldwide. Our operations are driven by accurate analysis and extensive coverage of all the areas to offer reliable reports.

Our study encompasses major growth determinants and drivers, along with extensive segmentation areas. Through in-depth analysis of supply and sales channels, including upstream and downstream fundamentals, we present a complete market ecosystem.

To ensure accuracy and reliability, our research leverages numerous primary and secondary sources. We employ industry-standard tools such as Porter's Five Forces Analysis, Swot Analysis, And Price Trend Analysis. Our extensive geographical coverage allows for a comprehensive understanding of regional trends and externally affecting factors.

Discount on the Research Report@

https://introspectivemarketresearch.com/discount/15919

Segmentation Analysis of The Influenza Diagnostics Market

Global Influenza Diagnostics Market Segmented on the basis of type, application, and end-users.

By Type     

  • Traditional
  • Rapid Influenza Detection Tests
  • Viral Culture
  • Immunoassay Kits
  • Molecular
  • Rapid Molecular Assays
  • Reverse Transcription-Polymerase Chain Reaction {Rt-Pcr}
  • Nucleic Acid Amplification

By End Users      

  • Clinical Laboratories
  • Hospitals
  • Research & Academic Institutes
  • Diagnostic Laboratories

Your Vision, Your Report - We'll Make It Happen!

https://introspectivemarketresearch.com/custom-research/15919

Global Influenza Diagnostics Market Regional Insights:

North American is Expected to Dominate the Market Over the Forecast period

For the duration of the estimate, the influenza diagnostic market share in North America is expected to be the largest. The primary factors driving the growth of the influenza diagnostic market in this region are the existence of top-tier businesses engaged in the production of influenza diagnostic products and the substantial government spending on the creation of cutting-edge rapid diagnostic methods to identify influenzas. The high frequency of seasonal flu and the growing use of sophisticated diagnostic tools are driving the influenza diagnostic market's growth during the forecast period.

By Region

  • North America (US, Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Finally, this Market Report is the authoritative source for market research that can dramatically accelerate your business. The report shows economic conditions such as major locales, item values, profits, limits, generation, supply, requirements, market development rates, and numbers.

Key Industry Developments in the Global Influenza Diagnostics Market:

In June 2022, BD (Becton, Dickinson, and Company) announced that the BD MAX Respiratory Viral Panel (RVP), a new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus (RSV), has been CE marked. The test uses a single nasal swab or a single nasopharyngeal swab sample to determine if a patient has COVID-19 or the flu or RSV. This product launch may help the company to enhance their market presence and generate increased business revenue.

In August 2022, Seegene launched a campaign to offer routine syndromic PCR testing for COVID-19, influenza A and B, and respiratory syncytial virus (RSV) in select settings in European and Asian markets. The campaign, called In-Life PCR, was launched 'preemptively' to curb transmission surges of COVID-19 and other respiratory viruses driven by relaxing public health precautions and increasing travel

Peace of Mind in a Purchase - Act Now!

https://introspectivemarketresearch.com/checkout/?user=1&_sid=15919

About us:

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends.

We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1 773 382 1049

Email: sales@introspectivemarketresearch.com

LinkedIn | Twitter | Facebook

About IMR Market Reports

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market.

Contact Information

IMR Market Reports

3001 S King Drive, Chicago, Illinois 60616, USA


USA
Phone :
View website

Published in

News

Published on

Jan 04, 2024

Social Links

PRnob Facebook Page LinkedIn page of PRnob.com